Article ; Online: Letter by Borst Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa Driven Platelet Activation via Protease Activated Receptor-1".
2020 Volume 126, Issue 8, Page(s) e53
MeSH term(s) | Humans ; Peptide Hydrolases ; Platelet Activation ; Receptor, PAR-1 ; Rivaroxaban ; Thrombosis/drug therapy ; Thrombosis/prevention & control |
---|---|
Chemical Substances | Receptor, PAR-1 ; Rivaroxaban (9NDF7JZ4M3) ; Peptide Hydrolases (EC 3.4.-) |
Language | English |
Publishing date | 2020-04-09 |
Publishing country | United States |
Document type | Letter ; Research Support, Non-U.S. Gov't ; Comment |
ZDB-ID | 80100-8 |
ISSN | 1524-4571 ; 0009-7330 ; 0931-6876 |
ISSN (online) | 1524-4571 |
ISSN | 0009-7330 ; 0931-6876 |
DOI | 10.1161/CIRCRESAHA.120.316777 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui IV Zs.70: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Ui IV Zs.60: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.